175 related articles for article (PubMed ID: 28024479)
21. [Vector construction and silencing effect of Edg4 gene targeted small interfering RNA in ovarian cancer cell line].
Qiao YH; Li LX; Guo RX; Zhou W; Wang M; Zhang XY; Zhang JH; Zhao XL; Zhang MZ; Zhao GQ
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):765-9. PubMed ID: 18307905
[TBL] [Abstract][Full Text] [Related]
22. [Inhibition effect of short hairpin RNA on VEGF receptor flt-1 gene expression in leukemia cell line K562].
Shen HL; Xu WL; Yuan W; Jian YW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Dec; 17(6):1413-8. PubMed ID: 20030917
[TBL] [Abstract][Full Text] [Related]
23. [Study on the targeting effects of M1-GS RNA on K562 cells].
Chen BB; Lin GW; Lu HZ; Fan HH; Gao L
Zhonghua Xue Ye Xue Za Zhi; 2004 Sep; 25(9):552-5. PubMed ID: 15569537
[TBL] [Abstract][Full Text] [Related]
24. [Overexpression of miR-30a Promotes Apoptosis of Leukemia K562 Cells].
Xu M; Gao WW; Luo YJ; Wang Y; Tao K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):396-402. PubMed ID: 30998144
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of p210(bcr/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90.
Wu LX; Xu JH; Huang XW; Zhang KZ; Wen CX; Chen YZ
Acta Pharmacol Sin; 2006 Jun; 27(6):694-9. PubMed ID: 16723087
[TBL] [Abstract][Full Text] [Related]
26. [Effect of phenylhexyl isothiocyanate on drug-resistance to imatinib in K562/G01 cell line].
Wu RJ; Huang YQ; Ma XD
Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):149-52. PubMed ID: 23611223
[TBL] [Abstract][Full Text] [Related]
27. [Construction of 293pT2-P210 cell line enables expression of bcr/abl to be regulated by Tet-off inducing-expression-system].
Huang WR; Lu ZZ; Wang LS; Wang H; Duan HF; Li QF; Gao CJ; DA WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):224-8. PubMed ID: 17493320
[TBL] [Abstract][Full Text] [Related]
28. Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells.
Cheong JW; Chong SY; Kim JY; Eom JI; Jeung HK; Maeng HY; Lee ST; Min YH
Clin Cancer Res; 2003 Oct; 9(13):5018-27. PubMed ID: 14581377
[TBL] [Abstract][Full Text] [Related]
29. [Stable interference on P210(bcr/abl) gene expression by lentiviral vector-delivered shRNA in vitro and in vivo].
Zhu YF; Wang YZ; Meng FY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Oct; 20(5):1090-4. PubMed ID: 23114125
[TBL] [Abstract][Full Text] [Related]
30. [Construction of a gastric cancer related gene GCRG213-specific siRNA expression vector and its effect on gastric cancer cells in vitro].
Gao LL; Wu BY; Wang MW; Zhan DW; Zhang L; You WD; Wang WH
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):84-8. PubMed ID: 17645837
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of bcr-abl and/or c-abl gene expression by small interfering, double-stranded RNAs: cross-talk with cell proliferation factors and other oncogenes.
Ohba H; Zhelev Z; Bakalova R; Ewis A; Omori T; Ishikawa M; Shinohara Y; Baba Y
Cancer; 2004 Sep; 101(6):1390-403. PubMed ID: 15368327
[TBL] [Abstract][Full Text] [Related]
32. [Inhibitory effect of the recombinant adenovirus pre-miR-10a on K562 cell proliferation].
Qi JY; Tao K; Wang CW; Li QH; Deng YP
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Oct; 28(10):1033-6. PubMed ID: 23046933
[TBL] [Abstract][Full Text] [Related]
33. [Influence of YB-1 protein on the biological behaviour in K562/A02 cells].
Shen HL; Zhou LL; Chen QY; Chen C; Fang LL; Fang XJ; Xu WL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):342-7. PubMed ID: 21518485
[TBL] [Abstract][Full Text] [Related]
34. [Effect on bcr-abl signaling pathway and the mechanisms of apoptosis induction by meisoindigo in K562 cells].
Liu BC; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):815-8. PubMed ID: 19176035
[TBL] [Abstract][Full Text] [Related]
35. [Detection of bcr-abl fusion gene mRNA level in K562/A02 cell line by real-time quantitative RT-PCR].
Chen BA; Zhou GN; Cheng J; Qiao C; Wu YJ; Li JY; Ding JH; Gao C; Zhao G; Wang J; Bao W; Song HH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):40-3. PubMed ID: 21362218
[TBL] [Abstract][Full Text] [Related]
36. Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells.
Koldehoff M; Zakrzewski JL; Beelen DW; Elmaagacli AH
Cancer Gene Ther; 2013 Jul; 20(7):421-7. PubMed ID: 23788109
[TBL] [Abstract][Full Text] [Related]
37. IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein.
Dilloo D; Hanenberg H; Lion T; Burdach S
Leukemia; 1995 Mar; 9(3):419-24. PubMed ID: 7885040
[TBL] [Abstract][Full Text] [Related]
38. The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.
Wei YL; Liang Y; Xu L; Zhao XY
Anat Rec (Hoboken); 2009 Jul; 292(7):945-50. PubMed ID: 19548306
[TBL] [Abstract][Full Text] [Related]
39. The nonviral episomal replicating vector pEPI-1 allows long-term inhibition of bcr-abl expression by shRNA.
Jenke AC; Eisenberger T; Baiker A; Stehle IM; Wirth S; Lipps HJ
Hum Gene Ther; 2005 Apr; 16(4):533-9. PubMed ID: 15871685
[TBL] [Abstract][Full Text] [Related]
40. [microRNA targeted to chronic myeloid leukemia Bcr-Abl oncogene screen using deacetylase inhibitor].
Ai ZD; Wu HY; Chen L
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(1):46-50. PubMed ID: 29343029
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
